Tidemark’s Colgate-Palmolive CL Stock Holding History

Tidemark’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.02K	Hold	33	–	–	﹤0.01%	651
2026 Q1	$2.81K	Buy	+33	New	+$2.94K	﹤0.01%	623

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Tidemark's CL Position: Q2 2026 in Review

Tidemark held its Colgate-Palmolive (CL) position steady in Q2 2026 at 33 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

Tidemark first reported a position in CL in Q1 2026 and has held it in 2 quarters since. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Tidemark held 33 shares of Colgate-Palmolive worth $3.02K as of Q2 2026.
Tidemark left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #651 holding.
Tidemark first reported a position in Colgate-Palmolive in Q1 2026 and has held it in 2 quarters since.
2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.